Charles River Laboratories (CRL)
EBITDA Growth
-31.73%
Quarterly · Period ending:
CRL EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-31.73%period ending
Latest reported-31.73%period ending
CRL Quarterly EBITDA YoY % (10.62% → -31.73%)
Year-over-year change
High-resolution chart · PNG
CRL ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -31.7313% | |
| -65.2867% | |
| -122.1404% | |
| -5.7009% | |
| -7.3844% | |
| -16.02% | |
| -126.7852% | |
| -6.9903% | |
| -1.1911% | |
| -9.5348% | |
| -9.6519% | |
| 7.8427% | |
| 7.6446% | |
| 23.9857% | |
| 47.3607% | |
| 0.3244% | |
| 5.8765% | |
| 24.1543% | |
| -9.0152% | |
| -2.4855% | |
| 31.9471% | |
| 23.2756% | |
| 46.5944% | |
| 63.5331% | |
| 24.452% | |
| 5.0569% | |
| 36.2825% | |
| -2.5378% | |
| -2.5331% | |
| 13.211% | |
| 20.9585% | |
| 17.5531% | |
| 13.9591% | |
| -8.5149% | |
| 3.2629% | |
| 20.7829% | |
| 21.3963% | |
| 46.0418% | |
| 34.5408% | |
| 16.8545% | |
| 8.8786% | |
| 40.2344% | |
| 15.062% | |
| 10.7714% | |
| 12.3197% | |
| -12.9% | |
| 24.8823% | |
| 1.391% | |
| 20.7018% | |
| 2.9701% | |
| 0.1088% | |
| 25.228% | |
| -4.9058% | |
| 0.5583% | |
| -13.2543% | |
| -0.3278% | |
| -9.4793% | |
| -0.563% | |
| 118.8127% | |
| 101.9511% | |
| 43.5737% | |
| 19.1566% | |
| -706.6827% | |
| -59.7064% | |
| -30.5854% | |
| -13.7667% | |
| 108.9141% | |
| -23.0301% | |
| -19.7561% | |
| -29.1109% | |
| -922.7501% | |
| 6.7631% | |
| 19.7743% | |
| 16.5571% | |
| 12.2516% | |
| 17.4632% | |
| 14.2525% | |
| 215.987% | |
| 7.0656% | |
| -10.611% | |
| 1.0711% | |
| -190.8587% | |
| 11.6937% | |
| 58.3451% | |
| 30.0275% | |
| 49.8354% | |
| 27.8239% | |
| 23.746% | |
| 23.2795% | |
| 16.2548% | |
| 16.9749% | |
| 6.4739% | |
| 16.1292% | |
| 19.9018% | |
| 23.4462% | |
| 24.9778% | |
| 16.2993% | |
| 35.431% | |
| 65.0396% | |
| 39.7967% |